DaVita Inc.

NYSE:DVA Stock Report

Market Cap: US$12.8b

DaVita Past Earnings Performance

Past criteria checks 4/6

DaVita's earnings have been declining at an average annual rate of -2.4%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 1.7% per year. DaVita's return on equity is 51%, and it has net margins of 6.5%.

Key information

-2.4%

Earnings growth rate

8.3%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate1.7%
Return on equity51.0%
Net Margin6.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Market Still Lacking Some Conviction On DaVita Inc. (NYSE:DVA)

Dec 15
Market Still Lacking Some Conviction On DaVita Inc. (NYSE:DVA)

DaVita's (NYSE:DVA) Returns On Capital Are Heading Higher

Nov 30
DaVita's (NYSE:DVA) Returns On Capital Are Heading Higher

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 14

Is DaVita Inc. (NYSE:DVA) Potentially Undervalued?

Nov 13
Is DaVita Inc. (NYSE:DVA) Potentially Undervalued?

Is DaVita (NYSE:DVA) A Risky Investment?

Oct 29
Is DaVita (NYSE:DVA) A Risky Investment?

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

Sep 16
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

Sep 01
DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Jul 02
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Jun 19
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Jun 04
Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

May 22
Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

DaVita Stock Is A Hold As It Expands In Latin America

Mar 18

Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Mar 13
Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Mar 04
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 16
DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Is DaVita (NYSE:DVA) Using Too Much Debt?

Feb 08
Is DaVita (NYSE:DVA) Using Too Much Debt?

DaVita: Assessing After The Rally

Dec 29

DaVita: Simple And Compelling After Sell-Off

Oct 26

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Oct 05

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Jul 21

DaVita HealthCare Partners Q4 2022 Earnings Preview

Feb 21

Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine

Feb 08

DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution

Dec 12

Revenue & Expenses Breakdown

How DaVita makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:DVA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2412,6678281,4970
30 Jun 2412,5248601,4930
31 Mar 2412,3388161,5050
31 Dec 2312,1406921,4740
30 Sep 2311,9115961,4520
30 Jun 2311,7394541,4410
31 Mar 2311,6655001,3920
31 Dec 2211,6105471,3550
30 Sep 2211,6376801,2980
30 Jun 2211,6278341,2260
31 Mar 2211,6169031,2090
31 Dec 2111,6199781,1950
30 Sep 2111,5809841,1770
30 Jun 2111,5668831,2470
31 Mar 2111,5297911,2300
31 Dec 2011,5517831,2480
30 Sep 2011,5448321,1860
30 Jun 2011,5248241,1220
31 Mar 2011,4878161,1160
31 Dec 1911,3887051,1030
30 Sep 1911,3116231,0930
30 Jun 1911,2535481,1310
31 Mar 1911,3005511,1200
31 Dec 1811,4126161,1350
30 Sep 1811,3786171,1200
30 Jun 1811,2996981,0570
31 Mar 1811,1106521,0560
31 Dec 1710,8849091,0520
30 Sep 177,7731,0657070
30 Jun 178,7321,4808250
31 Mar 179,7471,3829490
31 Dec 1610,6961,0381,0570
30 Sep 1614,5507161,5730
30 Jun 1614,3473611,5360
31 Mar 1614,0654781,4970
31 Dec 159,9733231,0310
30 Sep 1513,5654841,3990
30 Jun 1513,2904521,3690
31 Mar 1513,0274291,3190
31 Dec 1412,7817231,2620
30 Sep 1412,5197271,2240
30 Jun 1412,2706801,2070
31 Mar 1411,9717871,1760
31 Dec 1311,7596201,1760

Quality Earnings: DVA has high quality earnings.

Growing Profit Margin: DVA's current net profit margins (6.5%) are higher than last year (5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DVA's earnings have declined by 2.4% per year over the past 5 years.

Accelerating Growth: DVA's earnings growth over the past year (39%) exceeds its 5-year average (-2.4% per year).

Earnings vs Industry: DVA earnings growth over the past year (39%) exceeded the Healthcare industry 10.4%.

Return on Equity

High ROE: Whilst DVA's Return on Equity (51%) is outstanding, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 05:51
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DaVita Inc. is covered by 37 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephan GasteygerAtlantic Equities LLP
Brian WilliamsAvondale Partners
Matthew GillmorBaird